The FDA has begun the process of removing a powerful opioid from the market over concerns of the potential for abuse. Endo Pharmaceuticals was recently informed by the agency that it would like to see Opana ER pulled from the nation’s shelves.
Citing concerns over the “public health consequences of abuse,” the agency is giving Endo Pharmaceuticals the opportunity to voluntarily remove Opana ER on its ...
continue reading...
One of the least-known facts in medicine is the amount of leeway a doctor has when it comes to prescribing medicine. They are essentially on their own; the final authority in determining the drugs their patients will take while under their care. So, while the FDA may have approved a drug to treat X condition, biology dictates that it might also have a positive effect on Y condition, and your ...
